Reina Haque to Leukemia, Myelogenous, Chronic, BCR-ABL Positive
This is a "connection" page, showing publications Reina Haque has written about Leukemia, Myelogenous, Chronic, BCR-ABL Positive.
Connection Strength
0.593
-
Medication adherence, molecular monitoring, and clinical outcomes in patients with chronic myelogenous leukemia in a large HMO. J Am Pharm Assoc (2003). 2017 May - Jun; 57(3):303-310.e2.
Score: 0.593